1. Home
  2. AKTX

as 12-11-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).

Founded: N/A Country:
United States
United States
Employees: N/A City: BOSTON
Market Cap: 29.5M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 80.5K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.46 EPS Growth: N/A
52 Week Low/High: $0.90 - $4.40 Next Earning Date: 11-19-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

AKTX Daily Stock ML Predictions

Share on Social Networks: